AQST R&D to Revenue
Aquestive Therapeutics Inc · R&D to Revenue
AQST R&D to Revenue
Latest reported38.59%period ending
AQST FY R&D/Revenue (29.83% → 38.59%)
Latest values, visible window
High-resolution chart · PNG
AQST r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 38.5947% | |
| 35.2322% | |
| 25.9059% | |
| 36.6632% | |
| 33.536% | |
| 43.3728% | |
| 39.1074% | |
| 34.2755% | |
| 33.0748% | |
| 29.8349% |